Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Reuters continues to rate PTSC "Outperform"; comparisons interesting
earnings .06 x 39 = 2.34   still much better than where we are.
Share
New Message
Please login to post a reply